In focus · trending topic

inflammatory skin disease

7 stories · following the connections

Novan to Present Integrated Data from Phase 3 Trials with SB204 for Treatment of Acne

By Nasdaq OMXFeb 13, 2018, 1:05 PM UTC

Novan Announces First Patient Dosed in Phase 1b Atopic Dermatitis Trial with SB414

By Nasdaq OMXDec 5, 2017, 1:35 PM UTC

Novan Acquires IP Rights to Treat Viral Malignancies with Nitric Oxide

By Nasdaq OMXOct 18, 2017, 11:05 AM UTC

Novan to Present Safety and Efficacy Data for SB204 Program in Adolescents at 13th World Congress of Pediatric Dermatology

By Nasdaq OMXJul 7, 2017, 1:05 PM UTC

Novan Presents Preclinical Data from Inflammatory Skin Diseases Program

By Nasdaq OMXApr 27, 2017, 1:05 PM UTC

Novan Welcomes Key Opinion Leaders to New Advisory Council

By Nasdaq OMXApr 4, 2017, 1:05 PM UTC

Novan Announces Preclinical Data Demonstrating Immunomodulatory Effect In Vivo

By Nasdaq OMXNov 16, 2016, 2:05 PM UTC